Meeting the Challenges of an Emerging Pathogen: The Henry Schueler 41&9 Foundation International Forum on Mucormycosis
Open Access
- 1 February 2012
- journal article
- research article
- Published by Oxford University Press (OUP) in Clinical Infectious Diseases
- Vol. 54 (suppl_1), S1-S4
- https://doi.org/10.1093/cid/cir862
Abstract
Invasive mucormycosis comprises a group of uncommon but emerging life-threatening pulmonary, sinal, rhinocerebral, and disseminated infections, which cause debilitating morbidity and severe mortality in our most vulnerable pediatric and adult immunocompromised patients. While important advances are being achieved in understanding the epidemiology, molecular taxonomy, pathogenesis, pharmacology, host defenses, and microbiology of these infections, there are critical needs for improving these approaches for diagnosis, treatment, and prevention. This supplement is dedicated to the memory and courage of Hank Schueler, who fought valiantly against this infection. It provides a comprehensive resource for current approaches to management of this infection and also reviews the key advances against invasive mucormycosis.This publication has 5 references indexed in Scilit:
- Into the Winter WhitenessClinical Infectious Diseases, 2012
- Taxonomy of Fungi Causing Mucormycosis and Entomophthoramycosis (Zygomycosis) and Nomenclature of the Disease: Molecular Mycologic PerspectivesClinical Infectious Diseases, 2012
- Drosophila melanogaster as a model host to dissect the immunopathogenesis of zygomycosisProceedings of the National Academy of Sciences of the United States of America, 2008
- Epidemiology and Outcome of Zygomycosis: A Review of 929 Reported CasesClinical Infectious Diseases, 2005
- Interferon‐γ and Granulocyte‐Macrophage Colony‐Stimulating Factor Augment the Activity of Polymorphonuclear Leukocytes against Medically Important ZygomycetesThe Journal of Infectious Diseases, 2005